Atropine/hyoscyamine/phenobarbital/scopolamine

N-Biotinyl Dopamine.

N-Biotinyl Dopamine

N-Biotinyl Dopamine

N-Biotinyl Dopamine

Biochem/physiol Actions N-Octanoyl dopamine (NOD) protects cell cultures and tissues from cold storage inflicted damage. N-Octanoyl dopamine decreases lactate-dehydrogenase (LDH) release during cold storage of cardiomyocytes in vitro .

Competitive indoleamine 2,3-dioxygenase (IDO) inhibitor. Cell permeable, potent and selective necroptosis (a non-apoptotic form of programmed cell death) inhibitor.

Competitive indoleamine 2,3-dioxygenase (IDO) inhibitor. Cell permeable, potent and selective necroptosis (a non-apoptotic form of programmed cell death) inhibitor.

An atypical neuroleptic that blocks dopamine and serotonin (5-HT) receptors (Kis = 60, 30, and 30 nM for D2, D4, and 5-HT2A, respectively) an agonist for hM3Dq, a DREADD, with &gt10,000-fold selectivity for hM3Dq over hM3.

An atypical neuroleptic that blocks dopamine and serotonin (5-HT) receptors (Kis = 60, 30, and 30 nM for D2, D4, and 5-HT2A, respectively) an agonist for hM3Dq, a DREADD, with &gt10,000-fold selectivity for hM3Dq over hM3.

An atypical neuroleptic that blocks dopamine and serotonin (5-HT) receptors (Kis = 60, 30, and 30 nM for D2, D4, and 5-HT2A, respectively) an agonist for hM3Dq, a DREADD, with &gt10,000-fold selectivity for hM3Dq over hM3.

PG106 TFA is a potent and selective human melanocortin 3 (hMC3) receptor antagonist ( IC 50 = 210 nM) and has noactivity at hMC4 receptors ( EC 50 =9900 nM) and hMC5 receptor.Appearance:SolidIC50&amp: Target:MC3RBiological Activity:PG106 TFA is a

PG106 TFA is a potent and selective human melanocortin 3 (hMC3) receptor antagonist ( IC 50 = 210 nM) and has noactivity at hMC4 receptors ( EC 50 =9900 nM) and hMC5 receptor.Appearance:SolidIC50&amp: Target:MC3RBiological Activity:PG106 TFA is a